Our recent work did not identify differences in the percentage of CD69 and IFNγ positivity in unstimulated peripheral CD4+ and CD8+ T cells and NK cells from newly diagnosed glioblastoma patients versus healthy donors potentially due to the expected low levels of CD69 and IFNγ positivity when cells were unstimulated. The gene discussed is CD69; the disease is glioblastoma.